https://news.medxy.ai/ja/63247-2/Medxy AIja2026-08-13T08:14:42-07:00 https://news.medxy.ai/vi/2-hydroxybutyrate-test/Medxy AIvi2026-08-13T08:14:12-07:00Xét nghiệm enzym 2-hydroxybutyrate: công cụ sàng lọc mới giúp phát hiện rối loạn đường huyết vượt ra ngoài xét nghiệm lúc đói tiêu chuẩn https://news.medxy.ai/enzymatic-2-hydroxybutyrate-assay-a-novel-screening-tool-to-detect-dysglycemia-beyond-standard-fasting-tests/Medxy AIen2026-08-13T08:12:01-07:00Enzymatic 2-Hydroxybutyrate Assay: A Novel Screening Tool to Detect Dysglycemia Beyond Standard Fasting Tests https://news.medxy.ai/zh/fetal-cardiomyopathy/Medxy AIzh2026-08-13T08:09:32-07:00多中心北美队列揭示胎儿心肌病的预后进展与风险线索 https://news.medxy.ai/ja/fetal-cardiomyopathy-prognosis/Medxy AIja2026-08-13T08:09:01-07:00胎児心筋症の転帰と予後を読み解く：北米多施設コホートから見えた最新知見 https://news.medxy.ai/vi/fetal-cardiomyopathy-2/Medxy AIvi2026-08-13T08:07:18-07:00Bệnh cơ tim thai nhi trong kỷ nguyên hiện đại: tiến triển và những dấu ấn tiên lượng từ một đoàn hệ đa trung tâm Bắc Mỹ https://news.medxy.ai/progress-and-prognostic-insights-in-fetal-cardiomyopathy-findings-from-a-multicenter-north-american-cohort/Medxy AIen2026-08-13T08:03:35-07:00Progress and Prognostic Insights in Fetal Cardiomyopathy: Findings from a Multicenter North American Cohort https://news.medxy.ai/zh/vutrisiran-in-cardiac-structure-function-and-amyloid-burden-in-attr-cm/Medxy AIzh2026-08-13T08:02:41-07:00Vutrisiran 治疗与 ATTR-CM 患者心脏结构、功能及淀粉样蛋白负荷的心血管 MRI 变化 https://news.medxy.ai/ja/vutrisiran-attr-cm-mri/Medxy AIja2026-08-13T08:02:19-07:00Vutrisiran治療がATTR-CMの心構造・心機能・アミロイド負荷に及ぼす影響を心血管MRIで検証 https://news.medxy.ai/vi/vutrisiran-mri-amyloid/Medxy AIvi2026-08-13T08:01:43-07:00Vutrisiran và những thay đổi trên MRI tim mạch ở bệnh cơ tim amyloid transthyretin: cấu trúc, chức năng và gánh nặng amyloid https://news.medxy.ai/vutrisiran-treatment-and-cardiovascular-mri-detected-changes-in-cardiac-structure-function-and-amyloid-burden-in-attr-cm/Medxy AIen2026-08-13T07:58:51-07:00Vutrisiran Treatment and Cardiovascular MRI-Detected Changes in Cardiac Structure, Function, and Amyloid Burden in ATTR-CM https://news.medxy.ai/zh/beyond-bmi-waist-hip/Medxy AIzh2026-08-13T07:58:06-07:00超越BMI：腰围与腰臀比如何提升心血管风险预测 https://news.medxy.ai/ja/bmi-waist-hip-risk/Medxy AIja2026-08-13T07:57:43-07:00BMIだけでは不十分：ウエスト周囲径とウエスト・ヒップ比が心血管リスク予測をどう高めるか https://news.medxy.ai/vi/beyond-bmi-waist-hip-ratio/Medxy AIvi2026-08-13T07:57:16-07:00Vượt ra ngoài BMI: Vòng eo và tỷ lệ vòng eo/hông giúp dự đoán nguy cơ tim mạch chính xác hơn https://news.medxy.ai/beyond-bmi-how-waist-circumference-and-waist-to-hip-ratio-enhance-cardiovascular-risk-prediction/Medxy AIen2026-08-13T07:55:31-07:00Beyond BMI: How Waist Circumference and Waist-to-Hip Ratio Enhance Cardiovascular Risk Prediction https://news.medxy.ai/zh/myasthenia-gravis-antibody-test/Medxy AIzh2026-08-13T07:27:00-07:00重症肌无力抗体检测方法如何选？ADAM研究带来新证据 https://news.medxy.ai/ja/myasthenia-gravis-antibody-test-2/Medxy AIja2026-08-13T07:26:29-07:00重症筋無力症における抗体検査法を再考する：ADAM研究が示した知見 https://news.medxy.ai/vi/antibody-detection-myasthenia/Medxy AIvi2026-08-13T07:26:05-07:00Đánh giá các phương pháp phát hiện kháng thể trong bệnh nhược cơ: Những phát hiện từ nghiên cứu ADAM https://news.medxy.ai/evaluating-antibody-detection-methods-in-myasthenia-gravis-insights-from-the-adam-study/Medxy AIen2026-08-13T07:23:59-07:00Evaluating Antibody Detection Methods in Myasthenia Gravis: Insights from the ADAM Study https://news.medxy.ai/zh/fibroscan-liver-stiffness/Medxy AIzh2026-08-13T07:19:37-07:00Fibroscan® 肝脏硬度测量在原发性硬化性胆管炎预后评估中的价值：前瞻性 FICUS 队列研究新发现 https://news.medxy.ai/vi/liver-stiffness-prediction-2/Medxy AIvi2026-08-13T07:18:44-07:00Đo độ cứng gan có thực sự dự báo tiên lượng trong viêm đường mật xơ hóa nguyên phát? Dữ liệu từ đoàn hệ FICUS tiền cứu https://news.medxy.ai/validating-liver-stiffness-measurement-as-a-prognostic-tool-in-primary-sclerosing-cholangitis-insights-from-the-prospective-ficus-cohort/Medxy AIen2026-08-13T07:16:24-07:00Validating Liver Stiffness Measurement as a Prognostic Tool in Primary Sclerosing Cholangitis: Insights from the Prospective FICUS Cohort https://news.medxy.ai/zh/braf-v600-melanoma-survival/Medxy AIzh2026-08-13T00:09:57-07:00BRAF V600 突变晚期黑色素瘤中 Spartalizumab 联合 Dabrafenib 与 Trametinib 的长期生存获益：COMBI-I 试验启示 https://news.medxy.ai/ja/braf-v600-spartalizumab-benefit/Medxy AIja2026-08-13T00:09:32-07:00BRAF V600変異陽性進行悪性黒色腫におけるspartalizumab併用の長期生存ベネフィット：COMBI-I試験からの知見 https://news.medxy.ai/vi/spartalizumab-braf-trial/Medxy AIvi2026-08-13T00:09:09-07:00Spartalizumab kết hợp dabrafenib và trametinib mang lại lợi ích sống còn dài hạn ở u hắc tố tiến triển mang đột biến BRAF V600: Kết quả từ thử nghiệm COMBI-I https://news.medxy.ai/long-term-survival-benefit-of-spartalizumab-with-dabrafenib-and-trametinib-in-braf-v600-mutant-advanced-melanoma-insights-from-the-combi-i-trial/Medxy AIen2026-08-13T00:07:37-07:00Long-Term Survival Benefit of Spartalizumab with Dabrafenib and Trametinib in BRAF V600-Mutant Advanced Melanoma: Insights from the COMBI-I Trial https://news.medxy.ai/zh/left-atrial-volume-index-2/Medxy AIzh2026-08-12T10:49:58-07:00移植前左心房容积指数：预测肾移植后1年发病风险的新线索 https://news.medxy.ai/vi/left-atrial-volume-index/Medxy AIvi2026-08-12T10:49:13-07:00Chỉ số thể tích nhĩ trái trước ghép: Dấu ấn dự báo bệnh suất 1 năm sau ghép thận https://news.medxy.ai/pre-transplant-left-atrial-volume-index-as-a-predictor-of-one-year-morbidity-after-kidney-transplantation-insights-and-implications/Medxy AIen2026-08-12T10:47:07-07:00Pre-Transplant Left Atrial Volume Index as a Predictor of One-Year Morbidity after Kidney Transplantation: Insights and Implications https://news.medxy.ai/ja/donor-pancreas-transplant/Medxy AIja2026-08-12T10:46:22-07:00循環死後ドナー膵・膵島移植を変える常温区域灌流の可能性 https://news.medxy.ai/vi/body-circulation-physiology/Medxy AIvi2026-08-12T10:45:57-07:00Tuần hoàn vùng cơ thể ở nhiệt độ sinh lý: Bước ngoặt trong ghép tụy và ghép tiểu đảo tụy từ người hiến DCD https://news.medxy.ai/normothermic-regional-perfusion-a-paradigm-shift-in-pancreas-and-islet-transplantation-from-dcd-donors/Medxy AIen2026-08-12T10:45:01-07:00Normothermic Regional Perfusion: A Paradigm Shift in Pancreas and Islet Transplantation from DCD Donors https://news.medxy.ai/vi/pyoderma-gangrenosum-classification/Medxy AIvi2026-08-12T10:44:05-07:00Pyoderma gangrenosum: Khung phân loại thực hành từ đồng thuận chuyên gia https://news.medxy.ai/a-practical-framework-for-pyoderma-gangrenosum-expert-consensus-defines-phenotypes-and-modifiers/Medxy AIen2026-08-12T10:40:15-07:00A Practical Framework for Pyoderma Gangrenosum: Expert Consensus Defines Phenotypes and Modifiers https://news.medxy.ai/zh/confocal-microscopy-prediction/Medxy AIzh2026-08-12T10:39:57-07:00反射式共聚焦显微镜与深度学习助力面部特应性皮炎患者度普利尤单抗疗效的早期预测 https://news.medxy.ai/ja/dupilumab-effect-prediction/Medxy AIja2026-08-12T10:39:39-07:00反射型共焦点顕微鏡と深層学習による顔面アトピー性皮膚炎におけるデュピルマブ効果の早期予測 https://news.medxy.ai/vi/early-dupilumab-prediction/Medxy AIvi2026-08-12T10:39:19-07:00Dự đoán sớm hiệu quả của dupilumab trong viêm da cơ địa vùng mặt bằng kính hiển vi đồng tiêu phản xạ và học sâu https://news.medxy.ai/early-prediction-of-dupilumab-efficacy-in-facial-atopic-dermatitis-via-reflectance-confocal-microscopy-and-deep-learning/Medxy AIen2026-08-12T10:38:31-07:00Early Prediction of Dupilumab Efficacy in Facial Atopic Dermatitis via Reflectance Confocal Microscopy and Deep Learning https://news.medxy.ai/zh/breast-augmentation-analysis-2/Medxy AIzh2026-08-12T10:38:13-07:00组织保留与三维几何分析优化隆胸：临床要点与结局 https://news.medxy.ai/ja/breast-augmentation-analysis/Medxy AIja2026-08-12T10:37:55-07:00組織温存と3D幾何解析で磨く乳房増大術：臨床知見とその成果 https://news.medxy.ai/vi/breast-augmentation-3d-analysis/Medxy AIvi2026-08-12T10:37:25-07:00Nâng ngực tối ưu hóa nhờ bảo tồn mô và phân tích hình học 3D: góc nhìn lâm sàng và kết quả https://news.medxy.ai/optimizing-breast-augmentation-through-tissue-preservation-and-3d-geometric-analysis-clinical-insights-and-outcomes/Medxy AIen2026-08-12T10:36:13-07:00Optimizing Breast Augmentation Through Tissue Preservation and 3D Geometric Analysis: Clinical Insights and Outcomes https://news.medxy.ai/zh/botox-strategy-optimization/Medxy AIzh2026-08-12T10:35:53-07:00优化口角上提的肉毒毒素注射策略：一项严格两阶段随机试验的启示 https://news.medxy.ai/ja/botulinum-toxin-optimization-2/Medxy AIja2026-08-12T10:35:33-07:00口角挙上を最適化するボツリヌス毒素注射：厳密な2段階ランダム化試験から得られた知見 https://news.medxy.ai/vi/botulinum-toxin-optimization/Medxy AIvi2026-08-12T10:35:15-07:00Tối ưu hóa tiêm Botulinum toxin để nâng khóe miệng: Những phát hiện từ một thử nghiệm ngẫu nhiên hai giai đoạn nghiêm ngặt https://news.medxy.ai/optimizing-botulinum-toxin-injections-for-oral-commissure-elevation-insights-from-a-rigorous-two-stage-randomized-trial/Medxy AIen2026-08-12T10:34:01-07:00Optimizing Botulinum Toxin Injections for Oral Commissure Elevation: Insights from a Rigorous Two-Stage Randomized Trial https://news.medxy.ai/zh/childhood-trauma-bipolar-2/Medxy AIzh2026-08-12T10:33:40-07:00揭示儿童期创伤与躁郁症之间的神经生物学通路：来自 ENIGMA 联盟的研究见解 https://news.medxy.ai/vi/childhood-trauma-bipolar/Medxy AIvi2026-08-12T10:32:55-07:00Giải mã các con đường thần kinh sinh học nối sang chấn thời thơ ấu với rối loạn lưỡng cực: Góc nhìn từ ENIGMA Consortium https://news.medxy.ai/unraveling-the-neurobiological-pathways-linking-childhood-trauma-to-bipolar-disorder-insights-from-the-enigma-consortium/Medxy AIen2026-08-12T10:31:47-07:00Unraveling the Neurobiological Pathways Linking Childhood Trauma to Bipolar Disorder: Insights from the ENIGMA Consortium https://news.medxy.ai/zh/vasopressin-timing-sepsis/Medxy AIzh2026-08-12T10:31:30-07:00脓毒性休克中去甲肾上腺素升级后：超早期启动加压素是否优于早期启动？来自目标试验模拟的启示 https://news.medxy.ai/ja/vasopressin-sepsis-shock/Medxy AIja2026-08-12T10:31:12-07:00敗血症性ショックにおけるノルアドレナリン増量後のバソプレシン早期導入：ターゲットトライアル・エミュレーションからの知見 https://news.medxy.ai/vi/early-vasopressin-treatment/Medxy AIvi2026-08-12T10:30:52-07:00Khởi trị vasopressin siêu sớm sau khi tăng norepinephrine trong sốc nhiễm khuẩn: bằng chứng từ mô phỏng thử nghiệm mục tiêu https://news.medxy.ai/ultra-early-versus-early-vasopressin-initiation-after-norepinephrine-escalation-in-septic-shock-insights-from-a-target-trial-emulation/Medxy AIen2026-08-12T10:29:46-07:00Ultra-Early Versus Early Vasopressin Initiation After Norepinephrine Escalation in Septic Shock: Insights from a Target Trial Emulation https://news.medxy.ai/zh/icu-rrt-benefits-risks/Medxy AIzh2026-08-12T10:29:28-07:00ICU重症患者RRT的获益与风险：日本登记研究揭示治疗效应的复杂异质性 https://news.medxy.ai/ja/icu-renal-therapy-benefits-risks/Medxy AIja2026-08-12T10:29:10-07:00ICU重症患者における腎代替療法の利益とリスクを読み解く：日本レジストリからの知見 https://news.medxy.ai/vi/kidney-replacement-icu/Medxy AIvi2026-08-12T10:28:49-07:00Làm rõ lợi ích và nguy cơ phức tạp của liệu pháp thay thế thận ở bệnh nhân ICU: Góc nhìn từ một cơ sở đăng ký của Nhật Bản https://news.medxy.ai/unraveling-the-complex-benefits-and-risks-of-renal-replacement-therapy-in-icu-patients-insights-from-a-japanese-registry/Medxy AIen2026-08-12T10:28:00-07:00Unraveling the Complex Benefits and Risks of Renal Replacement Therapy in ICU Patients: Insights from a Japanese Registry https://news.medxy.ai/zh/empowering-internal-medicine-residents/Medxy AIzh2026-08-12T10:27:42-07:00赋能内科住院医师应对肥胖：资源不足城市门诊中的综合培训路径 https://news.medxy.ai/ja/obesity-care-clinic/Medxy AIja2026-08-12T10:27:23-07:00都市部の十分な医療資源が行き届きにくい診療所で進める肥満症対策：総合内科レジデント育成の包括的研修パス https://news.medxy.ai/vi/empowering-resident-physicians/Medxy AIvi2026-08-12T10:26:59-07:00Trao quyền cho bác sĩ nội trú nội khoa trong cuộc chiến chống béo phì: một lộ trình đào tạo toàn diện tại phòng khám đô thị thiếu nguồn lực https://news.medxy.ai/empowering-internal-medicine-residents-to-combat-obesity-a-comprehensive-training-pathway-in-an-underserved-urban-clinic/Medxy AIen2026-08-12T10:25:57-07:00Empowering Internal Medicine Residents to Combat Obesity: A Comprehensive Training Pathway in an Underserved Urban Clinic https://news.medxy.ai/zh/lung-cancer-screening-2/Medxy AIzh2026-08-12T10:25:40-07:00提升肺癌筛查依从性：来自健康沟通与分层提醒干预随机临床试验的启示 https://news.medxy.ai/ja/lung-cancer-screening/Medxy AIja2026-08-12T10:25:19-07:00肺がん検診の受診継続率を高めるには：健康コミュニケーションと段階的リマインダー介入のランダム化試験から得られた知見 https://news.medxy.ai/enhancing-lung-cancer-screening-adherence-insights-from-a-randomized-clinical-trial-of-health-communication-and-stepped-reminder-interventions/Medxy AIen2026-08-12T10:23:21-07:00Enhancing Lung Cancer Screening Adherence: Insights from a Randomized Clinical Trial of Health Communication and Stepped Reminder Interventions https://news.medxy.ai/zh/hallux-rigidus-surgery/Medxy AIzh2026-08-12T10:23:02-07:00拇趾僵硬症：手术融合术优于观察等待吗？——一项里程碑式随机对照试验的启示 https://news.medxy.ai/vi/arthrodesis-vs-waiting/Medxy AIvi2026-08-12T10:22:23-07:00Arthrodesis phẫu thuật hay theo dõi chờ đợi trong hallux rigidus: Góc nhìn từ một thử nghiệm ngẫu nhiên có đối chứng mang tính bước ngoặt https://news.medxy.ai/surgical-arthrodesis-versus-watchful-waiting-in-hallux-rigidus-insights-from-a-landmark-randomized-controlled-trial/Medxy AIen2026-08-12T10:21:38-07:00Surgical Arthrodesis Versus Watchful Waiting in Hallux Rigidus: Insights from a Landmark Randomized Controlled Trial https://news.medxy.ai/zh/sos-vod-incidence-risk-factors/Medxy AIzh2026-08-12T10:21:17-07:00成人异基因HSCT后SOS/VOD的真实世界发生率、危险因素与生物标志物验证：来自西班牙GETH-TC登记的证据 https://news.medxy.ai/vi/sos-vod-incidence-risk/Medxy AIvi2026-08-12T10:20:36-07:00Tỷ lệ mắc thực tế, yếu tố nguy cơ và xác thực dấu ấn sinh học SOS/VOD sau ghép đồng loài ở người lớn: Dữ liệu từ cơ sở đăng ký GETH-TC của Tây Ban Nha https://news.medxy.ai/real-world-incidence-risk-factors-and-biomarker-validation-for-sos-vod-after-allogeneic-hsct-in-adults-insights-from-the-spanish-geth-tc-registry/Medxy AIen2026-08-12T10:19:45-07:00Real-World Incidence, Risk Factors, and Biomarker Validation for SOS/VOD After Allogeneic HSCT in Adults: Insights from the Spanish GETH-TC Registry https://news.medxy.ai/zh/lenalidomide-azacitidine-radiotherapy/Medxy AIzh2026-08-12T10:19:23-07:00来那度胺与口服阿扎胞苷联合放疗治疗浆细胞瘤：一项先导试验及展望 https://news.medxy.ai/ja/lenalidomide-azacitidine-radiation/Medxy AIja2026-08-12T10:19:05-07:00形質細胞腫に対するレナリドミドと経口アザシチジン併用放射線治療：パイロット試験と今後の展望 https://news.medxy.ai/lenalidomide-and-oral-azacitidine-combined-with-radiotherapy-in-plasmacytoma-a-pilot-trial-and-perspectives/Medxy AIen2026-08-12T10:16:23-07:00Lenalidomide and Oral Azacitidine Combined with Radiotherapy in Plasmacytoma: A Pilot Trial and Perspectives https://news.medxy.ai/zh/usp8-b-cell-myeloma/Medxy AIzh2026-08-12T10:16:03-07:00USP8：B 细胞蛋白稳态与多发性骨髓瘤耐药的新靶点 https://news.medxy.ai/ja/b-cell-proteostasis-myeloma/Medxy AIja2026-08-12T10:15:45-07:00USP8を標的としたB細胞プロテオスタシスと多発性骨髄腫耐性の克服 https://news.medxy.ai/vi/usp8-potential-target/Medxy AIvi2026-08-12T10:15:24-07:00USP8: Đích điều trị tiềm năng trong proteostasis tế bào B và kháng đa u tủy https://news.medxy.ai/usp8-as-a-therapeutic-target-in-b-cell-proteostasis-and-multiple-myeloma-resistance/Medxy AIen2026-08-12T10:13:17-07:00USP8 as a Therapeutic Target in B Cell Proteostasis and Multiple Myeloma Resistance https://news.medxy.ai/zh/l-carnitine-regulation/Medxy AIzh2026-08-12T10:02:25-07:00l-肉碱调控人造血干/祖细胞再生的代谢机制：作用解析与治疗启示 https://news.medxy.ai/ja/l-carnitine-hematopoiesis/Medxy AIja2026-08-12T10:02:09-07:00l-カルニチンが切り開くヒト造血幹・前駆細胞再生の代謝制御：機序的洞察と治療応用 https://news.medxy.ai/zh/copd-beta-blocker-benefit/Medxy AIzh2026-08-12T09:59:50-07:00COPD合并心血管疾病患者使用β受体阻滞剂的生存获益：LABA联用的影响 https://news.medxy.ai/ja/beta-blockers-copd-cvd/Medxy AIja2026-08-12T09:59:33-07:00COPD合併心血管疾患におけるβ遮断薬の死亡率改善効果を読み解く：LABA併用の影響 https://news.medxy.ai/vi/beta-blockers-copd-benefits/Medxy AIvi2026-08-12T09:59:15-07:00Làm rõ lợi ích sống còn của thuốc chẹn beta ở bệnh nhân COPD có bệnh tim mạch: Ảnh hưởng của điều trị phối hợp LABA https://news.medxy.ai/unraveling-the-mortality-benefits-of-beta-blockers-in-copd-patients-with-cardiovascular-disease-influence-of-laba-co-therapy/Medxy AIen2026-08-12T09:57:46-07:00Unraveling the Mortality Benefits of Beta-Blockers in COPD Patients with Cardiovascular Disease: Influence of LABA Co-therapy https://news.medxy.ai/zh/post-tuberculosis-lung-damage/Medxy AIzh2026-08-12T09:57:25-07:00肺外结核后仍可持续受损：揭示结核后肺疾病的隐匿负担 https://news.medxy.ai/ja/post-tuberculosis-lung-damage-2/Medxy AIja2026-08-12T09:57:04-07:00肺外結核後も続く肺機能障害：見えにくい結核後肺疾患の負担を探る https://news.medxy.ai/vi/post-tb-lung-dysfunction/Medxy AIvi2026-08-12T09:56:41-07:00Rối loạn chức năng phổi kéo dài sau lao ngoài phổi: Làm rõ gánh nặng ẩn của bệnh phổi sau lao https://news.medxy.ai/persistent-lung-dysfunction-after-extra-pulmonary-tuberculosis-unveiling-the-hidden-burden-of-post-tb-lung-disease/Medxy AIen2026-08-12T09:55:29-07:00Persistent Lung Dysfunction After Extra-Pulmonary Tuberculosis: Unveiling the Hidden Burden of Post-TB Lung Disease https://news.medxy.ai/zh/scleral-fixation-iol/Medxy AIzh2026-08-12T09:55:11-07:00Yamane 巩膜内固定中的 IOL 公式屈光结局与预测准确性 https://news.medxy.ai/ja/yamane-iol-calculation/Medxy AIja2026-08-12T09:54:53-07:00Yamane強膜内固定におけるIOL度数計算式の屈折成績と予測精度 https://news.medxy.ai/vi/iol-power-prediction/Medxy AIvi2026-08-12T09:54:33-07:00Kết quả khúc xạ và độ chính xác dự đoán của các công thức tính công suất IOL trong cố định nội củng mạc theo Yamane https://news.medxy.ai/refractive-outcomes-and-predictive-accuracy-of-iol-power-formulas-in-yamane-intrascleral-fixation/Medxy AIen2026-08-12T09:53:18-07:00Refractive Outcomes and Predictive Accuracy of IOL Power Formulas in Yamane Intrascleral Fixation https://news.medxy.ai/ja/dual-focus-glasses-effectiveness/Medxy AIja2026-08-12T09:52:35-07:00小児近視抑制における双面複合デフォーカス眼鏡の有効性と安全性：エビデンスを総覧する https://news.medxy.ai/efficacy-and-safety-of-dual-sided-composite-defocus-spectacles-for-pediatric-myopia-control-a-comprehensive-evidence-review/Medxy AIen2026-08-12T09:50:16-07:00Efficacy and Safety of Dual-Sided Composite Defocus Spectacles for Pediatric Myopia Control: A Comprehensive Evidence Review https://news.medxy.ai/zh/tension-glottoplasty/Medxy AIzh2026-08-12T09:49:55-07:00张力性声门成形术：以生物力学创新推动声音女性化外科进展 https://news.medxy.ai/ja/voice-feminization-surgery/Medxy AIja2026-08-12T09:49:41-07:00張力付加声門形成術：生体力学的革新で切り開く声の女性化手術の新展開 https://news.medxy.ai/vi/tensioning-glottoplasty/Medxy AIvi2026-08-12T09:49:08-07:00Tensioning Glottoplasty: Bước tiến cơ sinh học trong phẫu thuật nữ tính hóa giọng nói https://news.medxy.ai/tensioning-glottoplasty-advancing-surgical-voice-feminization-with-biomechanical-innovation/Medxy AIen2026-08-12T09:47:57-07:00Tensioning Glottoplasty: Advancing Surgical Voice Feminization with Biomechanical Innovation https://news.medxy.ai/zh/robotic-pancreatectomy-assessment/Medxy AIzh2026-08-12T09:47:38-07:00日本全国机器人辅助远端胰切除术治疗恶性肿瘤的评估：安全性、结局与比较效果 https://news.medxy.ai/vi/robotic-distal-pancreatectomy-for-malignancy-safety-outcomes-and-comparative-effectiveness-in-japan/Medxy AIvi2026-08-12T09:47:00-07:00日本における悪性腫瘍に対するロボット支援下膵体尾部切除術の全国的評価：安全性、治療成績、および比較有効性 https://news.medxy.ai/nationwide-evaluation-of-robotic-distal-pancreatectomy-for-malignancy-safety-outcomes-and-comparative-effectiveness-in-japan/Medxy AIen2026-08-12T09:45:46-07:00Nationwide Evaluation of Robotic Distal Pancreatectomy for Malignancy: Safety, Outcomes, and Comparative Effectiveness in Japan https://news.medxy.ai/zh/us-injury-healthcare-analysis/Medxy AIzh2026-08-12T09:45:16-07:00美国伤害医疗支出全景分析：致伤机制、人口学特征与支付方视角 https://news.medxy.ai/ja/us-injury-medical-costs/Medxy AIja2026-08-12T09:44:58-07:00米国の傷害医療費を総覧する：機序、人口学的特性、支払者の視点から https://news.medxy.ai/vi/us-injury-healthcare-spending/Medxy AIvi2026-08-12T09:44:33-07:00Phân tích toàn diện chi tiêu y tế do chấn thương tại Hoa Kỳ: cơ chế, đặc điểm nhân khẩu học và góc nhìn của bên chi trả https://news.medxy.ai/comprehensive-analysis-of-us-health-care-spending-on-injuries-mechanisms-demographics-and-payer-perspectives/Medxy AIen2026-08-12T09:42:46-07:00Comprehensive Analysis of US Health Care Spending on Injuries: Mechanisms, Demographics, and Payer Perspectives https://news.medxy.ai/ja/endometrial-tumor-metabolic-surgery/Medxy AIja2026-08-12T09:42:24-07:00子宮内膜上皮内腫瘍・子宮体がん診療における代謝・肥満外科――SGO–SAGES 共同声明の要点 https://news.medxy.ai/vi/metabolic-bariatric-surgery/Medxy AIvi2026-08-12T09:41:46-07:00Phẫu thuật chuyển hóa và giảm cân trong chăm sóc tân sinh nội biểu mô nội mạc tử cung và ung thư nội mạc tử cung: Hướng dẫn then chốt từ tuyên bố chung SGO–SAGES https://news.medxy.ai/zh/endometrial-cancer-metabolism/Medxy AIzh2026-08-12T09:41:09-07:00子宫内膜上皮内瘤变与子宫内膜癌的代谢与减重手术：SGO–SAGES联合声明要点解读 https://news.medxy.ai/bariatric-surgery-endometrial-cancer/Medxy AIen2026-08-12T09:36:45-07:00Metabolic and Bariatric Surgery in the Care of Endometrial Intraepithelial Neoplasia and Endometrial Cancer: Key Guidance from the SGO–SAGES Joint Statement https://news.medxy.ai/zh/weight-loss-surgery-pregnancy/Medxy AIzh2026-08-12T09:21:22-07:00减重手术、妊娠期糖尿病与围产期结局：来自新南威尔士州大规模人群研究的启示 https://news.medxy.ai/ja/bariatric-surgery-pregnancy/Medxy AIja2026-08-12T09:21:03-07:00肥満手術と妊娠糖尿病は周産期転帰にどう影響するか：ニューサウスウェールズ州の大規模集団研究からの示唆 https://news.medxy.ai/vi/bariatric-surgery-gestational-diabetes/Medxy AIvi2026-08-12T09:20:43-07:00Phẫu thuật béo phì, đái tháo đường thai kỳ và kết cục chu sinh: Phát hiện từ một nghiên cứu quần thể quy mô lớn tại New South Wales https://news.medxy.ai/bariatric-surgery-gestational-diabetes-and-perinatal-outcomes-insights-from-a-large-population-based-study-in-new-south-wales/Medxy AIen2026-08-12T09:19:23-07:00Bariatric Surgery, Gestational Diabetes, and Perinatal Outcomes: Insights from a Large Population-Based Study in New South Wales https://news.medxy.ai/ja/neurodiversity-maternity-care/Medxy AIja2026-08-12T09:18:50-07:00神経多様性に配慮した産科ケア：妊娠・出産に役立つ実践的コミュニケーション戦略 https://news.medxy.ai/vi/neurodiverse-maternity-care/Medxy AIvi2026-08-12T09:18:13-07:00Chăm sóc sản khoa đáp ứng thần kinh đa dạng: Chiến lược giao tiếp thực hành cho thai kỳ và sinh nở https://news.medxy.ai/neurodivergent-responsive-obstetric-care-practical-communication-strategies-for-pregnancy-and-birth/Medxy AIen2026-08-12T09:13:36-07:00Neurodivergent-responsive obstetric care: Practical communication strategies for pregnancy and birth https://news.medxy.ai/ja/cancer-menopause-management/Medxy AIja2026-08-12T09:12:59-07:00がん患者の更年期管理：症状ベース・リスク層別化フレームワーク https://news.medxy.ai/vi/menopause-management-cancer/Medxy AIvi2026-08-12T09:12:14-07:00Quản lý mãn kinh ở bệnh nhân ung thư: Khung thực hành theo triệu chứng và phân tầng nguy cơ https://news.medxy.ai/zh/menopause-management-cancer-2/Medxy AIzh2026-08-12T09:11:34-07:00癌症患者的绝经管理：基于症状与风险分层的实用框架 https://news.medxy.ai/menopause-management/Medxy AIen2026-08-12T09:07:16-07:00Menopause Management in Patients with Cancer: A Symptom‑Based, Risk‑Stratified Framework https://news.medxy.ai/zh/hcc-fontan-liver-disease/Medxy AIzh2026-08-12T09:06:57-07:00解码Fontan相关肝病中的肝细胞癌：基因组与转录组新视角 https://news.medxy.ai/vi/liver-cancer-genomics/Medxy AIvi2026-08-12T09:06:18-07:00Giải mã ung thư biểu mô tế bào gan trong bệnh gan do Fontan: Những phát hiện từ genomic và transcriptomic https://news.medxy.ai/decoding-hepatocellular-carcinoma-in-fontan-associated-liver-disease-genomic-and-transcriptomic-insights/Medxy AIen2026-08-12T09:04:53-07:00Decoding Hepatocellular Carcinoma in Fontan-Associated Liver Disease: Genomic and Transcriptomic Insights https://news.medxy.ai/zh/il-10-antibodies-ibd/Medxy AIzh2026-08-12T09:04:33-07:00IL-10中和性自身抗体与儿童重症炎症性肠病及HLA-DRB1*01:03等位基因相关 https://news.medxy.ai/ja/il-10-autoantibodies/Medxy AIja2026-08-12T09:04:13-07:00IL-10中和自己抗体は重症小児炎症性腸疾患とHLA-DRB1*01:03アレルに関連する https://news.medxy.ai/vi/autoantibodies-il10-ibd/Medxy AIvi2026-08-12T09:03:55-07:00Tự kháng thể trung hòa chống IL-10 liên quan với IBD nhi khoa nặng và alen HLA-DRB1*01:03 https://news.medxy.ai/neutralising-autoantibodies-against-il-10-linked-to-severe-pediatric-inflammatory-bowel-disease-and-hla-drb10103-allele/Medxy AIen2026-08-12T09:02:41-07:00Neutralising Autoantibodies against IL-10 Linked to Severe Pediatric Inflammatory Bowel Disease and HLA-DRB1*01:03 Allele https://news.medxy.ai/zh/deep-learning-mr-perfusion/Medxy AIzh2026-08-12T09:02:22-07:00深度学习驱动的合成 MR 灌注图：急性缺血性卒中影像学的新突破 https://news.medxy.ai/ja/deep-learning-mri-perfusion/Medxy AIja2026-08-12T09:02:03-07:00深層学習で実現する合成MRI灌流マップ：急性虚血性脳卒中画像診断の新たな展開 https://news.medxy.ai/deep-learning-driven-synthetic-mr-perfusion-maps-a-breakthrough-in-acute-ischemic-stroke-imaging/Medxy AIen2026-08-12T08:59:56-07:00Deep Learning-Driven Synthetic MR Perfusion Maps: A Breakthrough in Acute Ischemic Stroke Imaging https://news.medxy.ai/zh/myasthenia-gravis-diagnosis/Medxy AIzh2026-08-12T08:55:48-07:00重症肌无力诊断再提升：细胞基于细胞检测在抗体检出中的优势更明显 https://news.medxy.ai/ja/myasthenia-gravis-diagnosis-3/Medxy AIja2026-08-12T08:55:28-07:00重症筋無力症診断を前進させる：抗体検出における細胞ベースアッセイの優れた精度 https://news.medxy.ai/vi/myasthenia-gravis-diagnosis-2/Medxy AIvi2026-08-12T08:55:07-07:00Nâng cao chẩn đoán bệnh nhược cơ: Xét nghiệm dựa trên tế bào cho độ chính xác vượt trội trong phát hiện kháng thể https://news.medxy.ai/advancing-myasthenia-gravis-diagnosis-the-superior-accuracy-of-cell-based-assays-in-antibody-detection/Medxy AIen2026-08-12T08:53:34-07:00Advancing Myasthenia Gravis Diagnosis: The Superior Accuracy of Cell-Based Assays in Antibody Detection https://news.medxy.ai/vi/parkinson-genetics/Medxy AIvi2026-08-12T08:52:40-07:00Bệnh học và di truyền trong một đoàn hệ toàn cầu các rối loạn Parkinson https://news.medxy.ai/pathology-and-genetics-in-a-global-cohort-of-parkinsonian-disorders/Medxy AIen2026-08-12T08:50:06-07:00Pathology and Genetics in a Global Cohort of Parkinsonian Disorders https://news.medxy.ai/zh/tc-max-anxiety-scale/Medxy AIzh2026-08-12T08:49:34-07:00甲状腺癌修订焦虑量表（TC-MAX）：评估癌症相关痛苦并指导以患者为中心照护的新工具 https://news.medxy.ai/ja/thyroid-cancer-anxiety-scale/Medxy AIja2026-08-12T08:48:56-07:00甲状腺がん修正版不安尺度（TC-MAX）：がん関連苦痛を評価し、患者中心のケアを導く新しいツール https://news.medxy.ai/vi/tc-max-anxiety-scale-2/Medxy AIvi2026-08-12T08:48:32-07:00TC-MAX: Thang đo lo âu sửa đổi dành cho ung thư tuyến giáp giúp nhận diện distress và định hướng chăm sóc lấy bệnh nhân làm trung tâm https://news.medxy.ai/the-thyroid-cancer-modified-anxiety-scale-tc-max-a-novel-tool-to-assess-cancer-related-distress-and-guide-patient-centered-care/Medxy AIen2026-08-12T08:46:32-07:00The Thyroid Cancer Modified Anxiety Scale (TC-MAX): A Novel Tool to Assess Cancer-Related Distress and Guide Patient-Centered Care https://news.medxy.ai/zh/parallel-training-fat-oxidation/Medxy AIzh2026-08-12T08:45:47-07:00并行训练可促进神经酰胺清除并增强2型糖尿病患者生活方式干预中的脂肪氧化 https://news.medxy.ai/ja/parallel-training-fatty-acid/Medxy AIja2026-08-12T08:45:15-07:00並行トレーニングはセラミドの除去を促し、2型糖尿病の脂肪酸酸化を高める https://news.medxy.ai/concurrent-training-augments-ceramide-clearance-and-enhances-fat-oxidation-in-type-2-diabetes-during-lifestyle-intervention/Medxy AIen2026-08-12T08:42:58-07:00Concurrent Training Augments Ceramide Clearance and Enhances Fat Oxidation in Type 2 Diabetes During Lifestyle Intervention https://news.medxy.ai/zh/cirrhosis-diabetes-guidelines/Medxy AIzh2026-08-12T08:42:27-07:00肝硬化合并糖尿病：实用临床管理指南 https://news.medxy.ai/ja/diabetes-liver-cirrhosis-guide/Medxy AIja2026-08-12T08:42:03-07:00肝硬変合併糖尿病をどう最適化するか：実践的臨床ガイド https://news.medxy.ai/vi/diabetes-management-cirrhosis/Medxy AIvi2026-08-12T08:41:37-07:00Tối ưu hóa quản lý đái tháo đường trong xơ gan: Hướng dẫn lâm sàng thực hành https://news.medxy.ai/optimizing-diabetes-management-in-cirrhosis-a-practical-clinical-guide/Medxy AIen2026-08-12T08:39:55-07:00Optimizing Diabetes Management in Cirrhosis: A Practical Clinical Guide https://news.medxy.ai/zh/tanzania-ai-diabetes-screening/Medxy AIzh2026-08-12T08:39:22-07:00坦桑尼亚可转诊性糖网检测：四种AI系统真实世界表现比较 https://news.medxy.ai/ja/comparative-performance-of-four-ai-systems-for-detecting-referable-diabetic-retinopathy/Medxy AIja2026-08-12T08:39:01-07:00タンザニアにおける専門医への紹介を要する糖尿病網膜症の検出を目的とした4つのAIシステムの性能比較：実臨床環境での評価 https://news.medxy.ai/vi/ai-retinopathy-detection-tanzania/Medxy AIvi2026-08-12T08:38:28-07:00So sánh hiệu năng của bốn hệ thống AI trong phát hiện bệnh võng mạc đái tháo đường có chỉ định chuyển tuyến tại Tanzania: đánh giá trong thực tế https://news.medxy.ai/comparative-performance-of-four-ai-systems-for-detecting-referable-diabetic-retinopathy-in-tanzania-a-real-world-evaluation/Medxy AIen2026-08-12T08:37:25-07:00Comparative Performance of Four AI Systems for Detecting Referable Diabetic Retinopathy in Tanzania: A Real-World Evaluation https://news.medxy.ai/zh/ai-ecg-monitoring/Medxy AIzh2026-08-12T08:37:04-07:00AI 赋能心电图能否成为肥厚型心肌病左心室功能障碍的新型监测工具？ https://news.medxy.ai/ja/hypertrophic-cardiomyopathy-ai/Medxy AIja2026-08-12T08:36:41-07:00マバカムテン治療中の肥大型心筋症における左室機能障害を捉えるAI搭載心電図の新たなサーベイランス手法 https://news.medxy.ai/vi/ai-ecg-monitoring-2/Medxy AIvi2026-08-12T08:36:17-07:00ECG hỗ trợ bởi AI: công cụ theo dõi mới cho rối loạn chức năng thất trái ở bệnh cơ tim phì đại điều trị bằng Mavacamten https://news.medxy.ai/ai-enabled-ecg-as-a-new-surveillance-tool-for-left-ventricular-dysfunction-in-hypertrophic-cardiomyopathy-on-mavacamten/Medxy AIen2026-08-12T08:34:22-07:00AI-Enabled ECG as a New Surveillance Tool for Left Ventricular Dysfunction in Hypertrophic Cardiomyopathy on Mavacamten https://news.medxy.ai/zh/unveiling-heart-failure-with-preserved-ejection-fraction-in-adults-with-congenital-heart-disease/Medxy AIzh2026-08-12T08:34:01-07:00揭示成人先天性心脏病患者射血分数保留型心力衰竭：患病率、特征及临床挑战 https://news.medxy.ai/ja/congenital-heart-failure/Medxy AIja2026-08-12T08:33:26-07:00先天性心疾患を有する成人における射出分画保持型心不全：有病率・臨床像・診療上の課題 https://news.medxy.ai/vi/hfpef-congenital-heart-disease/Medxy AIvi2026-08-12T08:32:54-07:00HFpEF ở người trưởng thành mắc bệnh tim bẩm sinh: Tỷ lệ hiện mắc, đặc điểm lâm sàng và những thách thức trong thực hành https://news.medxy.ai/unveiling-heart-failure-with-preserved-ejection-fraction-in-adults-with-congenital-heart-disease-prevalence-characteristics-and-clinical-challenges/Medxy AIen2026-08-12T08:30:49-07:00Unveiling Heart Failure with Preserved Ejection Fraction in Adults with Congenital Heart Disease: Prevalence, Characteristics, and Clinical Challenges https://news.medxy.ai/zh/sotatercept-pah-benefits/Medxy AIzh2026-08-12T08:30:21-07:00Sotatercept 在提升肺动脉高压患者运动能力中的多重作用 https://news.medxy.ai/ja/sotatercept-pah-benefits-2/Medxy AIja2026-08-12T08:27:53-07:00Sotaterceptが肺動脈性高血圧症の運動耐容能を高める多面的作用 https://news.medxy.ai/vi/sotatercept-pulmonary-hypertension/Medxy AIvi2026-08-12T08:26:59-07:00Sotatercept: Tác động đa cơ chế giúp cải thiện khả năng gắng sức trong tăng áp động mạch phổi https://news.medxy.ai/sotatercepts-multifaceted-role-in-enhancing-exercise-capacity-in-pulmonary-arterial-hypertension/Medxy AIen2026-08-12T08:24:37-07:00Sotatercept’s Multifaceted Role in Enhancing Exercise Capacity in Pulmonary Arterial Hypertension https://news.medxy.ai/harnessing-ai-enabled-ecg-for-early-detection-of-chagas-disease-a-new-frontier-in-cardiac-screening/Medxy AIen2026-08-12T08:22:31-07:00Harnessing AI-Enabled ECG for Early Detection of Chagas Disease: A New Frontier in Cardiac Screening https://news.medxy.ai/zh/nk-cell-dysfunction-mechanism/Medxy AIzh2026-08-11T22:43:29-07:00严重创伤后自然杀伤细胞功能失调的机制解析：免疫失衡与感染风险的启示 https://news.medxy.ai/ja/nk-cell-dysfunction-post-trauma/Medxy AIja2026-08-11T22:43:14-07:00重症外傷後のnatural killer細胞機能異常を読み解く：免疫調節異常と感染リスクへの示唆 https://news.medxy.ai/vi/natural-killer-cell-dysfunction/Medxy AIvi2026-08-11T22:42:55-07:00Giải mã rối loạn chức năng tế bào giết tự nhiên sau chấn thương nặng: Ý nghĩa đối với rối loạn điều hòa miễn dịch và nguy cơ nhiễm trùng https://news.medxy.ai/zh/sepsis-resuscitation-impact/Medxy AIzh2026-08-11T22:31:08-07:00院前 1 小时复苏包对脓毒性休克病死率的影响：来自 SAMU Save Sepsis 研究的启示 https://news.medxy.ai/ja/sepsis-resuscitation/Medxy AIja2026-08-11T22:30:46-07:00院前1時間蘇生バンドルは敗血症性ショックの死亡率を改善できるか：SAMU Save Sepsis試験からの知見 https://news.medxy.ai/vi/sepsis-shock-impact/Medxy AIvi2026-08-11T22:30:27-07:00Đánh giá tác động của gói hồi sức 1 giờ trước nhập viện đối với tử vong do sốc nhiễm khuẩn: Những phát hiện từ nghiên cứu SAMU Save Sepsis https://news.medxy.ai/evaluating-the-impact-of-a-prehospital-1-hour-resuscitation-bundle-on-septic-shock-mortality-insights-from-the-samu-save-sepsis-study/Medxy AIen2026-08-11T22:28:58-07:00Evaluating the Impact of a Prehospital 1-Hour Resuscitation Bundle on Septic Shock Mortality: Insights from the SAMU Save Sepsis Study https://news.medxy.ai/functional-impairment-of-natural-killer-cells-after-severe-trauma-phenotypic-shifts-and-loss-of-activating-receptors/Medxy AIen2026-08-11T22:22:43-07:00Functional Impairment of Natural Killer Cells After Severe Trauma: Phenotypic Shifts and Loss of Activating Receptors https://news.medxy.ai/zh/rocuronium-dose-intubation/Medxy AIzh2026-08-11T22:22:23-07:00罗库溴铵剂量是否影响危重患者首次插管成功率？多中心试验二次分析带来新线索 https://news.medxy.ai/ja/rocuronium-intubation-effect/Medxy AIja2026-08-11T22:22:06-07:00重症患者の初回挿管成功に対するロクロニウム投与量の影響：多施設試験の二次解析からの知見 https://news.medxy.ai/vi/rocuronium-intubation-success/Medxy AIvi2026-08-11T22:21:45-07:00Tác động của liều Rocuronium đến tỷ lệ thành công đặt ống nội khí quản ở lần thử đầu tiên ở bệnh nhân nguy kịch: góc nhìn từ phân tích thứ cấp các thử nghiệm đa trung tâm https://news.medxy.ai/impact-of-rocuronium-dose-on-first-attempt-intubation-success-in-critically-ill-patients-insights-from-a-secondary-analysis-of-multicenter-trials/Medxy AIen2026-08-11T22:20:03-07:00Impact of Rocuronium Dose on First-Attempt Intubation Success in Critically Ill Patients: Insights from a Secondary Analysis of Multicenter Trials